secwatch.observer — SEC 8-K summary
======================================

Issuer:     Envoy Medical, Inc. (COCH)
CIK:        0001840877
Form:       8-K
Filed at:   2026-02-27T23:59:59+00:00
Accession:  0001213900-26-021116
Event type: regulatory
Sentiment:  positive
Materiality: 0.60
Item codes: 3.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Envoy Medical regains compliance with Nasdaq listing requirement after MVLS deficiency
--------------------------------------------------------------------------------

- Received Nasdaq letter confirming compliance with Listing Rule 5550(b)(2) after MVLS fell below $35M.
- Discretionary panel monitor imposed for one year from February 12, 2026.
- Company implemented strategic financing initiatives to strengthen balance sheet and regain compliance.
- Original non-compliance notice received February 25, 2025; now resolved.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840877/000121390026021116/0001213900-26-021116-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840877/000121390026021116/envoy-8k_022326.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-021116

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer